ZLY28
Product Specifications
Target
FXR
Related Pathways
Metabolism
Bioactivity
ZLY28 is a novel, first-in-class compound with specific intestinal restriction and oral activity, serving as a dual modulator of FXR and FABP1. Additionally, it is a pioneering anti-NASH agent, utilized in the study of nonalcoholic steatohepatitis (NASH) [1].
Molecular Formula
C29H23Cl2NO4
Molecular Weight
520.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15373601 1 Vial
Lentiviral human LZTR1 sgRNA gene knockout kit - Lentiviral human LZTR1 sgRNA gene knockout kit (plasmid)
Sign In for Pricing
View Details 
orb3055171-01 50 µg
Recombinant Influenza A virus (H7N9) NR (N) -3M2e Protein, N-His
Sign In for Pricing
View Details orb3055171-02 100 µg
Recombinant Influenza A virus (H7N9) NR (N) -3M2e Protein, N-His
Sign In for Pricing
View Details